Table 1.
Association of risk score of signature with clinical features in pancreatic cancer.
TCGA dataset | ICGC dataset | |||
---|---|---|---|---|
Risk score | P value | Risk score | P value | |
Age | ||||
>60 years | 11.314 ± 0.707 | 0.144 | 10.719 ± 0.345 | 0.456 |
<60 years | 11.467 ± 0.621 | 10.767 ± 0.395 | ||
Gender | ||||
Female | 11.381 ± 0.668 | 0.773 | 10.737 ± 0.358 | 0.919 |
Male | 11.351 ± 0.696 | 10.732 ± 0.364 | ||
Grade | ||||
G1 | 10.765 ± 1.15 | 0.002 | 10.749 ± 0.358 | 0.016 |
G2 + G32 + G4 | 11.487 ± 0.455 | 10.444 ± 0.298 | ||
T stage | ||||
T1 + T2 | 10.919 ± 1.138 | 0.014 | 10.788 ± 0.283 | 0.264 |
T3 + T4 | 11.459 ± 0.493 | 10.723 ± 0.374 | ||
N stage | ||||
N0 | 11.22 ± 0.903 | 0.153 | 10.741 ± 0.352 | 0.889 |
N1 + N2 + Nx | 11.42 ± 0.569 | 10.732 ± 0.364 | ||
M stage | ||||
M0 | 11.457 ± 0.485 | 0.088 | 10.548 ± 0.158 | 0.165 |
M1 + Mx | 11.289 ± 0.802 | 10.738 ± 0.362 | ||
Clinical stage | ||||
I + II | 11.374 ± 0.667 | 0.571 | ||
III + IV | 11.2 ± 0.926 | |||
Chemotherapy | ||||
Yes | 11.29 ± 0.79 | 0.276 | ||
No | 11.42 ± 0.61 | |||
Radiation | ||||
Yes | 11.39 ± 0.59 | 0.941 | ||
No | 11.38 ± 0.70 |